A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF EVEROLIMUS, AN ORAL MTOR INHIBITOR, IN SUBJECTS WITH IMPAIRED HEPATIC FUNCTION Article Peveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z. EUROPEAN JOURNAL OF CANCER. ELSEVIER SCI LTD. Vol. 47. 2011.
VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN NONPREGNANT HUMAN ENDOMETRIUM AND ITS GENETIC POLYMORPHISMS: CONTRIBUTION TO RECURRENT PREGNANCY LOSS Article Sadekova O.N., Nikitina L.A., Rashidov T.N., Demidova E.M., Samokhodskaya L.M. Placenta. W.B. Saunders Ltd. Vol. 32. 2011.